Risedronate’s Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis

Osteoporosis is a significant concern for postmenopausal women and is a critical factor in hip fracture. Examining evidence for osteoporosis medications in hip fracture is important for optimizing treatment. PURPOSE: Review risedronate’s role for hip fracture in postmenopausal women. METHODS: A lite...

Descripción completa

Detalles Bibliográficos
Autores principales: Gates, Brian J., Das, Shyamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Expert Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260522/
https://www.ncbi.nlm.nih.gov/pubmed/22267947
http://dx.doi.org/10.4137/CMAMD.S4092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260522/
https://www.ncbi.nlm.nih.gov/pubmed/22267947
http://dx.doi.org/10.4137/CMAMD.S4092

Ejemplares similares